Maven Securities LTD Harpoon Therapeutics, Inc. Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $56,900 - $78,300	-10,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $4.8 Million - $8.52 Million	-608,610 Reduced 98.38%	10,000 $79,000
Q2 2021 Aug 16, 2021	BUY	$13.81 - $23.25 $6.75 Million - $11.4 Million	488,610 Added 375.85%	618,610 $8.46 Million
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $2.01 Million - $2.75 Million	113,800 Added 702.47%	130,000 $2.6 Million
Q4 2020 Feb 12, 2021	BUY	$12.83 - $17.84 $207,846 - $289,008	16,200 New	16,200 $269,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.